[Management strategy on hypertension induced by anti-cancer therapy with vascular endothelial growth factor inhibitor].

Yang, X L; Guan, B; Lyu, H C; Jiang, Y N; Xia, Y L

Yang, X L; Guan, B; Lyu, H C; Jiang, Y N; Xia, Y L.

Afiliação

Yang XL; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Guan B; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Lyu HC; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Jiang YN; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Xia YL; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.

Zhonghua Xin Xue Guan Bing Za Zhi ; 49(10): 957-962, 2021 Oct 24.

Article em Zh | MEDLINE | ID: mdl-34674433

Assuntos

Hipertensão; Fator A de Crescimento do Endotélio Vascular; Endotélio Vascular; Humanos; Hipertensão/induzido quimicamente; Hipertensão/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator A de Crescimento do Endotélio Vascular / Hipertensão Limite: Humans Idioma: Zh Revista: Zhonghua Xin Xue Guan Bing Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google